Mauna Kea Technologies | Mutual Funds

Mutual Funds that own Mauna Kea Technologies

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
FORUM Family Office Value Fund - Spezial
516,560
2.23%
450,415
4.67%
06/30/2018
464,583
2%
359,524
2.33%
07/31/2018
450,000
1.94%
50,000
0.73%
12/31/2017
LBPAM Actions Santé
76,535
0.33%
0
0.17%
06/29/2018
Hochactions France
54,377
0.24%
-11,765
0.56%
12/29/2017
HSBC Micro Caps Euro
52,075
0.23%
0
0.27%
12/29/2017
MG Expansion France
50,000
0.22%
50,000
1.05%
12/29/2017
Gestys Santé Biotech
50,000
0.22%
-10,000
4.55%
03/23/2018
Pure Capital Fund SICAV - Conviction European Equities
45,000
0.19%
20,000
0.51%
06/30/2017
Actys 1
32,830
0.14%
0
0.28%
06/29/2018

About Mauna Kea Technologies

View Profile
Address
9, rue d'Enghien
Paris Ile-de-France 75010
France
Employees -
Website http://www.maunakeatech.com
Updated 07/08/2019
Mauna Kea Technologies SA is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases. The company engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. Its product, Cellvizio, a probe-based Confocal Laser Endomicroscopy system, provides physicians and researchers high resolution cellular views of tissue inside the body.